These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34228254)

  • 1. Overcoming COVID-19 in China despite shortcomings of the public health system: what can we learn?
    Wang MM; Fleßa S
    Health Econ Rev; 2021 Jul; 11(1):25. PubMed ID: 34228254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 3. The Use of Digital Tools to Mitigate the COVID-19 Pandemic: Comparative Retrospective Study of Six Countries.
    Zeng K; Bernardo SN; Havins WE
    JMIR Public Health Surveill; 2020 Dec; 6(4):e24598. PubMed ID: 33302255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Control: Can Germany Learn From China?
    Müller O; Lu G; Jahn A; Razum O
    Int J Health Policy Manag; 2020 Oct; 9(10):432-435. PubMed ID: 32610735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations.
    Wu J; Wang J; Nicholas S; Maitland E; Fan Q
    J Med Internet Res; 2020 Oct; 22(10):e21980. PubMed ID: 33001836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to COVID-19 in the Central African Republic: Coping Strategies Combined With China's Experience.
    Gou Q; Zhu F; Xie K; Li Y; Xie Y
    Int J Public Health; 2022; 67():1604344. PubMed ID: 35548685
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. China health technology and stringency containment measures during COVID-19 pandemic: A discussion of first and second wave of COVID-19.
    Abbas HSM; Xu X; Sun C
    Health Technol (Berl); 2021; 11(2):405-410. PubMed ID: 33462559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.
    Ke Y; Cui J; Wong Y
    J Epidemiol Glob Health; 2021 Mar; 11(1):42-45. PubMed ID: 33009735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures Undertaken in China to Avoid COVID-19 Infection: Internet-Based, Cross-Sectional Survey Study.
    Huang Y; Wu Q; Wang P; Xu Y; Wang L; Zhao Y; Yao D; Xu Y; Lv Q; Xu S
    J Med Internet Res; 2020 May; 22(5):e18718. PubMed ID: 32396516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between China and Brazil in the Two Waves of COVID-19 Prevention and Control.
    Liu M; Shi L; Chen H; Wang X; Yang M; Jiao J; Yang J; Sun G
    J Epidemiol Glob Health; 2022 Jun; 12(2):168-181. PubMed ID: 35353368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the possibility of China reaching carbon emission peak by 2030 in the context of the COVID-19 pandemic.
    Chen T; Ren Y; Yang J; Cong G
    Environ Sci Pollut Res Int; 2023 Nov; 30(52):111995-112018. PubMed ID: 37824049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on Monetary Policy Implementation and Industrial Structure Transformation Under COVID-19-Evidence From Eight Economic Zones in Mainland China.
    Zhou B; Wang S; Gao H; Wang H
    Front Public Health; 2022; 10():865699. PubMed ID: 35669741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Public Health Containment Measures of COVID-19 in China and India.
    Chen H; Shi L; Zhang Y; Wang X; Jiao J; Yang M; Sun G
    Risk Manag Healthc Policy; 2021; 14():3323-3332. PubMed ID: 34408516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the level of social distancing necessary to avoid future COVID-19 epidemic waves: a modelling study for North East London.
    Cheetham N; Waites W; Ebyarimpa I; Leber W; Brennan K; Panovska-Griffiths J
    Sci Rep; 2021 Mar; 11(1):5806. PubMed ID: 33707546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.